MedImmune Explores a Therapeutic Lead for Treatment of Type 2 Diabetes and Obesity
SMI Reports (13.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382.
London, United Kingdom, April 15, 2016 --(PR.com)-- SMi's 3rd Peptides Conference and Exhibition returns to London on 6th and 7th of July. With peptide therapeutics at the forefront of drug development for treatment of various diseases due to their efficacy, safety and stability, SMi’s 3rd Peptides Conference and Exhibition will provide the perfect platform to analyse and discuss recent advancements within the industry. Registration is now live on www.peptidesevent.com/prcom
SMi is proud to announce that Lutz Jermutus, Senior Director for R&D and Product Development Team Leader at MedImmune, will be chairing the conference with Dan Teufel, Head of Chemistry at Bicycle Therapeutics Ltd.
Mr Jermutus will be opening the conference with a keynote presentation which explores MED10382 as a promising therapeutic lead for the treatment of Type 2 diabetes and obesity. The presentation will provide an overview of pre-clinical and clinical development of the novel GLP1/glucagon co-agonist, as well as the mechanisim of action studies.
Other notable speakers include
· Dan Teufel, Head of Chemistry, Bicycle Therapeutics
· Leila Hassani-Beniddir, Senior Scientist-Novel drug delivery technologies, Ipsen Limited
· Mathias Schoffrath, Group Leader Chromatography, Sanofi-Aventis
· Saif Shubber, Scientist, MedImmune
· Ashok Bhandari, Vice President, Chemistry, Protagonist Therapeutics
· Gary Bembridge, Director of Scientific Affairs Immunology, Abzena
· Oliver Demmer, Innovation Consultant, Ministry of Foreign Affairs of Denmark
The event also offers two pre-conference workshops on 5th July 2016:
· Workshop A: Cyclic Peptides: Discovery, Development and Deployment
Hosted by Bicycle Therapeutics and Proxima Concepts
· Workshop B: Cell Penetrating Peptides: a Powerful New Tool for Cellular Research
Hosted by Cupid Peptides
The full agenda can be viewed on the event website at www.peptidesevent.com/prcom where you can download a complimentary brochure and register attendance.
For tailored sponsorship and branding opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk. For media enquiries contact Honey de Gracia on +44 (0) 20 7827 6102 or email hdegracia@smi-online.co.uk
3rd Peptides Event
6-7 July 2016
London, UK
Event Website: www.peptidesevent.com/prcom
SMi is proud to announce that Lutz Jermutus, Senior Director for R&D and Product Development Team Leader at MedImmune, will be chairing the conference with Dan Teufel, Head of Chemistry at Bicycle Therapeutics Ltd.
Mr Jermutus will be opening the conference with a keynote presentation which explores MED10382 as a promising therapeutic lead for the treatment of Type 2 diabetes and obesity. The presentation will provide an overview of pre-clinical and clinical development of the novel GLP1/glucagon co-agonist, as well as the mechanisim of action studies.
Other notable speakers include
· Dan Teufel, Head of Chemistry, Bicycle Therapeutics
· Leila Hassani-Beniddir, Senior Scientist-Novel drug delivery technologies, Ipsen Limited
· Mathias Schoffrath, Group Leader Chromatography, Sanofi-Aventis
· Saif Shubber, Scientist, MedImmune
· Ashok Bhandari, Vice President, Chemistry, Protagonist Therapeutics
· Gary Bembridge, Director of Scientific Affairs Immunology, Abzena
· Oliver Demmer, Innovation Consultant, Ministry of Foreign Affairs of Denmark
The event also offers two pre-conference workshops on 5th July 2016:
· Workshop A: Cyclic Peptides: Discovery, Development and Deployment
Hosted by Bicycle Therapeutics and Proxima Concepts
· Workshop B: Cell Penetrating Peptides: a Powerful New Tool for Cellular Research
Hosted by Cupid Peptides
The full agenda can be viewed on the event website at www.peptidesevent.com/prcom where you can download a complimentary brochure and register attendance.
For tailored sponsorship and branding opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk. For media enquiries contact Honey de Gracia on +44 (0) 20 7827 6102 or email hdegracia@smi-online.co.uk
3rd Peptides Event
6-7 July 2016
London, UK
Event Website: www.peptidesevent.com/prcom
Contact
SMi Group
Honey de Gracia
+44 (0) 207 827 6093
http://www.peptidesevent.com/prcom
Honey de Gracia
+44 (0) 207 827 6093
http://www.peptidesevent.com/prcom
Contact
Categories